Tempus ECG-Low EF vs QFR
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need an AI-powered solution for early identification of patients at risk for heart failure, particularly those aged 40 or older. This tool is ideal for screening in primary care, emergency medicine, or internal medicine settings to quickly flag individuals who may require further cardiac evaluation based on a standard 12-lead ECG.
View Tempus ECG-Low EF →Choose QFR if…
Choose QFR if your focus is on advanced, quantitative assessment of coronary artery lesions during or after X-ray angiography. This software is best suited for cardiologists in the cath lab who require precise anatomical quantification, 3D reconstruction, and functional significance (QFR) analysis to guide interventional decisions for coronary vessel segments.
View QFR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | QFR |
|---|---|---|
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | On-premise (integrates into cath lab environment) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) offers a simpler, more accessible workflow by analyzing standard 12-lead ECGs and providing a binary output, making it easier for a wider range of clinicians to integrate into their practice. QFR (Tool B), while designed for seamless integration into cath labs, involves more complex imaging analysis and requires specialized training for its users.
Clinical Value
TieBoth tools offer significant clinical value with FDA clearance and supporting evidence. Tempus ECG-Low EF provides early risk identification for heart failure from routine ECGs, demonstrating good sensitivity and specificity. QFR aids in critical interventional decision-making by offering quantitative flow ratio analysis from angiographic images, supported by extensive clinical evidence and ESC guidelines.
Pricing & Value
QFRWhile both tools require contacting the vendor for specific pricing, QFR (Tool B) offers a transparent 'Pay per Use Model' with analysis tokens. This flexible pricing structure allows healthcare facilities to pay for actual utilization, potentially offering better perceived value and cost control compared to Tool A's undisclosed pricing.
Enterprise Readiness
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) demonstrates stronger enterprise readiness, originating from Tempus AI, a large and established company. It explicitly states HIPAA compliance and offers a Business Associate Agreement (BAA), alongside its integration into healthcare facility workflows and EHRs. QFR (Tool B)'s HIPAA compliance is noted as 'unknown (likely),' which is less explicit.
Innovation
TieBoth tools showcase significant innovation in their respective cardiology domains. Tempus ECG-Low EF (Tool A) innovatively applies deep learning to standard ECGs for widespread, non-invasive screening of low LVEF. QFR (Tool B) leverages AI for 3D reconstruction and wire-free, adenosine-free functional assessment from angiographic images, streamlining invasive procedures.
Support & Docs
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) offers more comprehensive and explicitly documented support channels, including customer support via email and phone, a resource center with educational materials, and API documentation. QFR (Tool B) provides support for installation and a user manual, but less extensive public documentation on ongoing support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | QFR |
|---|---|---|
| Name | Tempus ECG-Low EF | QFR |
| Company | Tempus AI | QFR Solutions bv |
| Description | Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. | QFR by QFR Solutions bv is an FDA-cleared AI-powered medical software for the visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments, aiding cardiologists in lesion assessment. |
| Primary Function | Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%) from ECGs | Quantitative Flow Ratio (QFR) analysis of X-ray angiographic images for lesion assessment |
| Target Patient Population | Patients 40+ years at risk of heart failure | Not specified |
| Key Feature Example | AI-powered algorithm for ECG analysis | 3D reconstruction of coronary vessel models |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and QFR.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or QFR
Backers
Who funded each tool's parent company.